Jointly Provided by American Academy of CME and CheckRare CE

Supported by an educational grant from Xeris Pharmaceuticals, Inc.

Start date: September 30, 2022
End date: September 29, 2023
Estimated time to complete: 0.5 hours

NO LONGER AVAILABLE FOR CREDIT

Activity Description

This 30 minute CME program highlights the latest expert consensus on best practices for diagnosing Cushing’s disease and managing the comorbidities commonly observed in persons with this rare disorder.

Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor. Optimal patient outcomes require an accurate diagnosis, proper selection of individualized treatment, and good management of the disease and its associated comorbidities.

The program features two experts, Beverly Biller, MD, Professor of Medicine at Harvard Medical School and Maria Fleseriu, MD, Professor of Medicine and Neurological Surgery at Oregon Health and Science University, who were actively involved in the recently published consensus on the diagnosis and management of Cushing’s disease in Lancet Diabetes Endocrinology.

Activity Faculty

Beverly MK Biller, MD
Professor of Medicine
Harvard Medical School
Neuroendocrine Clinical Center
Massachusetts General Hospital

Maria Fleseriu, MD, FACE
Professor Medicine and Neurological Surgery
Director Pituitary Center
Oregon Health and Science University

Target Audience

This activity has been designed to meet the educational needs of physicians specializing in endocrinology, radiology, and neurosurgery. Other members of the care team may also participate.

Learning Objective

After participating in the activity, learners should be better able to:

• Identify best practices from the new consensus summary on Cushing’s disease for diagnosing, locating tumor, and addressing potential comorbidities and complications.
• Incorporate the latest guidance on Cushing’s disease into patient care.

Accreditation and Credit Designation

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of relevant financial relationships are as follows:

Faculty Educators

Dr. Biller discloses the following relevant financial relationships with ineligible companies:

• Consultant: HRA Pharma, Recordati, Sparrow
• Grant/Research Support: Millendo,* Novartis,* Xeris (formerly Strongbridge)*

Dr. Fleseriu discloses the following relevant financial relationships with ineligible companies:

• Advisory Board/Consultant: HRA Pharma, Recordati, Sparrow, Xeris (formerly Strongbridge)
• Grant/Research Support: Recordati, Sparrow, Xeris (formerly Strongbridge)

*relationship has ended

Planners for this activity have no relevant financial relationships with any ineligible companies.

This activity will review off-label or investigational information.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you in within 30 days.

Hardware/Software Requirements

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection

Privacy

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm. For more information about CheckRare’s privacy policy, please access https://checkrare.com/privacy/

Contact

For any questions, please contact: CEServices@academycme.org

Copyright

© 2022. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).